Tocqueville Asset Management’s Bioventus BVS Stock Holding History

Tocqueville Asset Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49M	Buy	369,673 +24,673	+7%	+$236K	0.05%	250
2026 Q1	$3.15M	Buy	345,000 +15,000	+5%	+$126K	0.05%	247
2025 Q4	$2.46M	Buy	330,000 +25,000	+8%	+$180K	0.04%	279
2025 Q3	$2.04M	Buy	305,000 +70,000	+30%	+$486K	0.03%	298
2025 Q2	$1.56M	Buy	+235,000	New	+$1.67M	0.02%	315

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tocqueville Asset Management's BVS Position: Q2 2026 in Review

Tocqueville Asset Management increased its Bioventus (BVS) stake by 7.2% in Q2 2026, buying an estimated $236K and bringing the position to 369,673 shares worth $3.49M. The position accounts for 0.05% of the portfolio, ranked #250.

Tocqueville Asset Management first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Tocqueville Asset Management held 369,673 shares of Bioventus worth $3.49M as of Q2 2026.
Tocqueville Asset Management bought 24,673 Bioventus shares in Q2 2026, an estimated $236K.
Bioventus made up 0.05% of Tocqueville Asset Management's portfolio in Q2 2026, its #250 holding.
Tocqueville Asset Management first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.